ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Brief description of study

For subjects age 18 years and older who are at an increased risk for HCC and for whom HCC surveillance is appropriate, including subjects with cirrhosis or non-cirrhotic subjects with Hepatitis B. Approximately 3,000 subjects are expected to be enrolled, comprised of approximately 2,222 ultrasound surveillance subjects and 778 subjects under surveillance with CT/MRI.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Hepatocellular Carcinoma,Carcinoma,cirrhosis
Age: Between 18 Years - 99 Years
Gender: All

Male and Female Age 18 or older Diagnosis of cirrhosis

Updated on 09 Mar 2024. Study ID: 849567

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).